1. Home
  2. FC vs TRML Comparison

FC vs TRML Comparison

Compare FC & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FC
  • TRML
  • Stock Information
  • Founded
  • FC 1983
  • TRML 2021
  • Country
  • FC United States
  • TRML United States
  • Employees
  • FC N/A
  • TRML N/A
  • Industry
  • FC Other Consumer Services
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • FC Consumer Discretionary
  • TRML Health Care
  • Exchange
  • FC Nasdaq
  • TRML Nasdaq
  • Market Cap
  • FC 468.0M
  • TRML 419.1M
  • IPO Year
  • FC 1992
  • TRML N/A
  • Fundamental
  • Price
  • FC $36.02
  • TRML $22.72
  • Analyst Decision
  • FC Strong Buy
  • TRML Strong Buy
  • Analyst Count
  • FC 3
  • TRML 3
  • Target Price
  • FC $63.33
  • TRML $65.00
  • AVG Volume (30 Days)
  • FC 60.0K
  • TRML 179.1K
  • Earning Date
  • FC 01-02-2025
  • TRML 11-07-2024
  • Dividend Yield
  • FC N/A
  • TRML N/A
  • EPS Growth
  • FC 40.32
  • TRML N/A
  • EPS
  • FC 1.74
  • TRML N/A
  • Revenue
  • FC $287,233,000.00
  • TRML N/A
  • Revenue This Year
  • FC $7.22
  • TRML N/A
  • Revenue Next Year
  • FC $16.28
  • TRML N/A
  • P/E Ratio
  • FC $20.70
  • TRML N/A
  • Revenue Growth
  • FC 2.39
  • TRML N/A
  • 52 Week Low
  • FC $33.75
  • TRML $12.12
  • 52 Week High
  • FC $44.96
  • TRML $48.31
  • Technical
  • Relative Strength Index (RSI)
  • FC 38.73
  • TRML 35.49
  • Support Level
  • FC $35.13
  • TRML $25.58
  • Resistance Level
  • FC $40.15
  • TRML $27.51
  • Average True Range (ATR)
  • FC 1.35
  • TRML 1.80
  • MACD
  • FC -0.41
  • TRML -0.62
  • Stochastic Oscillator
  • FC 9.86
  • TRML 2.12

About FC Franklin Covey Company

Franklin Covey Co is a global company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education practice, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the United States and other international countries.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: